UPEXI INC (UPXI) Stock Price & Overview

NASDAQ:UPXIUS39959A2050

Current stock price

1.17 USD
+0.11 (+10.38%)
At close:
1.1598 USD
-0.01 (-0.87%)
Pre-Market:

The current stock price of UPXI is 1.17 USD. Today UPXI is up by 10.38%. In the past month the price increased by 107.04%. In the past year, price decreased by -47.77%.

UPXI Key Statistics

52-Week Range0.54 - 22.57
Current UPXI stock price positioned within its 52-week range.
1-Month Range0.54 - 1.28
Current UPXI stock price positioned within its 1-month range.
Market Cap
81.619M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-5.29
Dividend Yield
N/A

UPXI Stock Performance

Today
+10.38%
1 Week
+8.33%
1 Month
+107.04%
3 Months
-37.43%
Longer-term
6 Months -77.56%
1 Year -47.77%
2 Years -89.93%
3 Years -98.56%
5 Years N/A
10 Years N/A

UPXI Stock Chart

UPEXI INC / UPXI Daily stock chart

UPXI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to UPXI. When comparing the yearly performance of all stocks, UPXI is a bad performer in the overall market: 93.24% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

UPXI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to UPXI. UPXI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UPXI Earnings

On February 10, 2026 UPXI reported an EPS of -2.94 and a revenue of 8.05M. The company missed EPS expectations (-5664.71% surprise) and missed revenue expectations (-16.2% surprise).

Next Earnings DateMay 12, 2026
Last Earnings DateFeb 10, 2026
PeriodQ2 / 2026
EPS Reported-$2.94
Revenue Reported8.052M
EPS Surprise -5,664.71%
Revenue Surprise -16.20%

UPXI Forecast & Estimates

8 analysts have analysed UPXI and the average price target is 5.1 USD. This implies a price increase of 335.9% is expected in the next year compared to the current price of 1.17.

For the next year, analysts expect an EPS growth of -3.8% and a revenue growth 120.96% for UPXI


Analysts
Analysts82.5
Price Target5.1 (335.9%)
EPS Next Y-3.8%
Revenue Next Year120.96%

UPXI Groups

Sector & Classification

Index Membership

UPXI Financial Highlights

Over the last trailing twelve months UPXI reported a non-GAAP Earnings per Share(EPS) of -5.29. The EPS increased by 75.76% compared to the year before.


Income Statements
Revenue(TTM)24.74M
Net Income(TTM)-122.93M
Industry RankSector Rank
PM (TTM) N/A
ROA -45.34%
ROE -252.35%
Debt/Equity 4.25
Chartmill High Growth Momentum
EPS Q2Q%-136.29%
Sales Q2Q%101.02%
EPS 1Y (TTM)75.76%
Revenue 1Y (TTM)329.54%

UPXI Ownership

Ownership
Inst Owners26.81%
Shares69.76M
Float56.90M
Ins Owners8.09%
Short Float %31.57%
Short Ratio3.32

About UPXI

Company Profile

UPXI logo image Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Company Info

IPO: 2021-06-24

UPEXI INC

3030 Rocky Point Drive, Suite 420

Tampa FLORIDA US

Employees: 59

UPXI Company Website

UPXI Investor Relations

Phone: 17013535425

UPEXI INC / UPXI FAQ

Can you describe the business of UPEXI INC?

Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 59 full-time employees. The company went IPO on 2021-06-24. The firm is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.


Can you provide the latest stock price for UPEXI INC?

The current stock price of UPXI is 1.17 USD. The price increased by 10.38% in the last trading session.


Does UPEXI INC pay dividends?

UPXI does not pay a dividend.


What is the ChartMill technical and fundamental rating of UPXI stock?

UPXI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Is UPEXI INC (UPXI) expected to grow?

The Revenue of UPEXI INC (UPXI) is expected to grow by 120.96% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the ownership details for UPXI stock?

You can find the ownership structure of UPEXI INC (UPXI) on the Ownership tab.